Company Directory / biotechnology
PrivateFor profitbiotechnologyWatertown, United States
Lyndra Therapeutics
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
- Founded
- 2015 11 years ago
- Staff
- 101-250 band, as listed
- Followers
- - on LinkedIn
- Funding
- $285M as listed, currency not stated
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed
Age
11 years old.
Reach
Website ranked #6,091,633 in the world for traffic, about 1k visits a month.
What it does
BiotechnologyClinical TrialsHealth CarePharmaceutical
Funding, as listed
$285M currency not stated
- Rounds7
- LatestSeries e, Dec 2023
- Investors22, 4 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Lyndra Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Lyndra Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2015
- Founders
- Amy Schulman, Andrew Bellinger, Colin R. Gardner, Giovanni Traverso
- Industry
- biotechnology
- Categories
- Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Where
- City
- Watertown
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 101-250
- Web traffic rank
- #6,091,633
- Monthly web visits
- 1,127
Funding, as listed
- Total
- 284,632,584 (currency not stated)
- Rounds
- 7
- Latest round
- Series e
- Latest round date
- Dec 2023
- Investors
- 22
- Lead investors
- 4
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Lyndra Therapeutics may be growing as evidenced by a significant raise of one hundred and one million dollars in Series E funding, which suggests investor confidence and financial resources for expansion or research and development. Additionally, the company has attracted a substantial investment from Sun Pharma, which has agreed to purchase a sixteen percent stake for approximately two hundred and forty-nine crore rupees. Further solidifying its financial position, Sun Pharma is set to acquire a sixteen point seven percent stake in Lyndra Therapeutics for thirty million dollars, indicating a strategic partnership and an infusion of capital.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
biotechnology in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.